United Therapeutics Corporation shares owned by Victory Capital Management
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Victory Capital Management
from 13F filings
Historical chart of Victory Capital Management investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by Victory Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in United Therapeutics Corporation by Victory Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $46M | 110k | 419.21 |
| 2025-06-30 | $114M | 397k | 287.35 |
| 2025-03-31 | $76M | 246k | 308.27 |
| 2024-12-31 | $68M | 193k | 352.84 |
| 2024-09-30 | $67M | 187k | 358.35 |
| 2024-06-30 | $49M | 153k | 318.55 |
| 2024-03-31 | $33M | 145k | 229.72 |
| 2023-12-31 | $30M | 134k | 219.89 |
| 2023-09-30 | $7.4M | 33k | 225.87 |
| 2023-06-30 | $5.0M | 23k | 220.75 |
| 2023-03-31 | $6.4M | 29k | 223.96 |
| 2022-12-31 | $5.9M | 23k | 263.17 |
| 2022-09-30 | $4.5M | 22k | 209.39 |
| 2022-06-30 | $3.8M | 16k | 235.63 |
| 2022-03-31 | $2.8M | 16k | 177.59 |
| 2021-12-31 | $2.6M | 12k | 216.07 |
| 2021-09-30 | $2.3M | 13k | 184.57 |
| 2021-06-30 | $2.4M | 13k | 179.38 |
| 2021-03-31 | $2.5M | 15k | 167.24 |
| 2020-12-31 | $2.4M | 16k | 151.79 |
| 2020-09-30 | $2.0M | 20k | 100.98 |
| 2020-06-30 | $2.5M | 21k | 120.99 |
| 2020-03-31 | $2.1M | 23k | 94.82 |
| 2019-12-31 | $924k | 11k | 88.06 |
| 2019-09-30 | $813k | 10k | 79.79 |
| 2019-06-30 | $2.5M | 33k | 78.06 |
| 2019-03-31 | $2.7M | 23k | 117.37 |
| 2018-12-31 | $2.4M | 22k | 108.90 |
| 2018-09-30 | $2.8M | 22k | 127.88 |
| 2017-06-30 | $850k | 6.5k | 129.79 |
| 2017-03-31 | $733k | 5.4k | 135.34 |
| 2016-12-31 | $715k | 5.0k | 143.46 |
| 2016-09-30 | $519k | 4.4k | 118.09 |
More positions owned by Victory Capital Management
View all positions for Victory Capital Management
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation